383 related articles for article (PubMed ID: 17525745)
1. Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes.
Pollock PM; Gartside MG; Dejeza LC; Powell MA; Mallon MA; Davies H; Mohammadi M; Futreal PA; Stratton MR; Trent JM; Goodfellow PJ
Oncogene; 2007 Nov; 26(50):7158-62. PubMed ID: 17525745
[TBL] [Abstract][Full Text] [Related]
2. FGFR2 as a molecular target in endometrial cancer.
Byron SA; Pollock PM
Future Oncol; 2009 Feb; 5(1):27-32. PubMed ID: 19243295
[TBL] [Abstract][Full Text] [Related]
3. Utilization of unlabeled probes for the detection of fibroblast growth factor receptor 2 exons 7 and 12 mutations in endometrial carcinoma.
Liu T; Willmore-Payne C; Wallander ML; Layfield LJ
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):341-6. PubMed ID: 21285871
[TBL] [Abstract][Full Text] [Related]
4. FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Jeske YW; Ali S; Byron SA; Gao F; Mannel RS; Ghebre RG; DiSilvestro PA; Lele SB; Pearl ML; Schmidt AP; Lankes HA; Ramirez NC; Rasty G; Powell M; Goodfellow PJ; Pollock PM
Gynecol Oncol; 2017 May; 145(2):366-373. PubMed ID: 28314589
[TBL] [Abstract][Full Text] [Related]
5. [The molecular genetic background of hereditary craniosynostoses and chondrodysplasias].
Hertz JM; Juncker I; Christensen L; Østergaard JR; Jensen PK
Ugeskr Laeger; 2001 Sep; 163(36):4862-7. PubMed ID: 11571861
[TBL] [Abstract][Full Text] [Related]
6. FGFR2 mutations are rare across histologic subtypes of ovarian cancer.
Byron SA; Gartside MG; Wellens CL; Goodfellow PJ; Birrer MJ; Campbell IG; Pollock PM
Gynecol Oncol; 2010 Apr; 117(1):125-9. PubMed ID: 20106510
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor receptor inhibition synergizes with Paclitaxel and Doxorubicin in endometrial cancer cells.
Byron SA; Loch DC; Pollock PM
Int J Gynecol Cancer; 2012 Nov; 22(9):1517-26. PubMed ID: 23060048
[TBL] [Abstract][Full Text] [Related]
8. Activity of the fibroblast growth factor receptor inhibitors dovitinib (TKI258) and NVP-BGJ398 in human endometrial cancer cells.
Konecny GE; Kolarova T; O'Brien NA; Winterhoff B; Yang G; Qi J; Qi Z; Venkatesan N; Ayala R; Luo T; Finn RS; Kristof J; Galderisi C; Porta DG; Anderson L; Shi MM; Yovine A; Slamon DJ
Mol Cancer Ther; 2013 May; 12(5):632-42. PubMed ID: 23443805
[TBL] [Abstract][Full Text] [Related]
9. Drug-sensitive FGFR2 mutations in endometrial carcinoma.
Dutt A; Salvesen HB; Chen TH; Ramos AH; Onofrio RC; Hatton C; Nicoletti R; Winckler W; Grewal R; Hanna M; Wyhs N; Ziaugra L; Richter DJ; Trovik J; Engelsen IB; Stefansson IM; Fennell T; Cibulskis K; Zody MC; Akslen LA; Gabriel S; Wong KK; Sellers WR; Meyerson M; Greulich H
Proc Natl Acad Sci U S A; 2008 Jun; 105(25):8713-7. PubMed ID: 18552176
[TBL] [Abstract][Full Text] [Related]
10. FGFR2 alterations in endometrial carcinoma.
Gatius S; Velasco A; Azueta A; Santacana M; Pallares J; Valls J; Dolcet X; Prat J; Matias-Guiu X
Mod Pathol; 2011 Nov; 24(11):1500-10. PubMed ID: 21725289
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast Growth Factor Receptor 2 (
Azoury SC; Reddy S; Shukla V; Deng CX
Int J Biol Sci; 2017; 13(12):1479-1488. PubMed ID: 29230096
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutations.
Kim DH; Kwak Y; Kim ND; Sim T
Cancer Biol Ther; 2016; 17(1):65-78. PubMed ID: 26574622
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation.
Byron SA; Gartside MG; Wellens CL; Mallon MA; Keenan JB; Powell MA; Goodfellow PJ; Pollock PM
Cancer Res; 2008 Sep; 68(17):6902-7. PubMed ID: 18757403
[TBL] [Abstract][Full Text] [Related]
14. The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors.
Byron SA; Chen H; Wortmann A; Loch D; Gartside MG; Dehkhoda F; Blais SP; Neubert TA; Mohammadi M; Pollock PM
Neoplasia; 2013 Aug; 15(8):975-88. PubMed ID: 23908597
[TBL] [Abstract][Full Text] [Related]
15. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
[TBL] [Abstract][Full Text] [Related]
16. Quantification of facial skeletal shape variation in fibroblast growth factor receptor-related craniosynostosis syndromes.
Heuzé Y; Martínez-Abadías N; Stella JM; Arnaud E; Collet C; García Fructuoso G; Alamar M; Lo LJ; Boyadjiev SA; Di Rocco F; Richtsmeier JT
Birth Defects Res A Clin Mol Teratol; 2014 Apr; 100(4):250-9. PubMed ID: 24578066
[TBL] [Abstract][Full Text] [Related]
17. FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features.
Byron SA; Gartside M; Powell MA; Wellens CL; Gao F; Mutch DG; Goodfellow PJ; Pollock PM
PLoS One; 2012; 7(2):e30801. PubMed ID: 22383975
[TBL] [Abstract][Full Text] [Related]
18. FGFR2-activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer cell models.
Stehbens SJ; Ju RJ; Adams MN; Perry SR; Haass NK; Bryant DM; Pollock PM
J Cell Sci; 2018 Aug; 131(15):. PubMed ID: 30002137
[TBL] [Abstract][Full Text] [Related]
19. Genotype-Phenotype Correlation of Tracheal Cartilaginous Sleeves and Fgfr2 Mutations in Mice.
Lam AS; Liu CC; Deutsch GH; Rivera J; Perkins JA; Holmes G; Jabs EW; Cunningham ML; Dahl JP
Laryngoscope; 2021 Apr; 131(4):E1349-E1356. PubMed ID: 32886384
[TBL] [Abstract][Full Text] [Related]
20. Bent bone dysplasia (BBD)-FGFR2 type: the radiologic manifestations in early gestation.
Handa A; Okajima Y; Izumi N; Yamanaka M; Kurihara Y
Pediatr Radiol; 2016 Feb; 46(2):296-9. PubMed ID: 26446305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
